title: 5. Tanstuzumab treatment for breast cancer.
authors.affiliation: Division of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. khatake@jfcr.or.jp
authors.forename: Kiyohiko
authors.initials: K
authors.lastname: Hatake
authors.forename: Nahomi
authors.initials: N
authors.lastname: Tokudome
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Ito
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000502:physiology; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab